Nanobac Pharmaceuticals, Incorporated (NNBP)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 3, 2026
Nanobac Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | 2002 |
|---|---|---|---|---|---|---|
Period Ending | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | Dec '04 Dec 31, 2004 | Dec '03 Dec 31, 2003 | 2002 |
| Net Income | -6.58 | -4.97 | -3.69 | -8.52 | -3.7 | Upgrade
|
| Depreciation & Amortization | 0.46 | 0.54 | 0.76 | 0.72 | 0.18 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.02 | 0 | - | 0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.59 | - | - | - | Upgrade
|
| Stock-Based Compensation | 1.71 | 0.67 | 0.01 | 2.56 | 0.78 | Upgrade
|
| Other Operating Activities | 1.74 | 0.24 | 0.79 | 0.88 | - | Upgrade
|
| Change in Accounts Receivable | -0 | 0 | 0 | 0 | 0.01 | Upgrade
|
| Change in Inventory | 0.06 | 0.05 | -0.05 | -0.05 | 0.07 | Upgrade
|
| Change in Accounts Payable | 0.67 | 0.09 | -0.33 | 0.53 | 0.28 | Upgrade
|
| Change in Unearned Revenue | - | -0.02 | 0.01 | 0.02 | - | Upgrade
|
| Change in Other Net Operating Assets | 1.03 | 0.21 | 0.13 | 0.47 | 0.22 | Upgrade
|
| Operating Cash Flow | -0.91 | -2.58 | -2.37 | -3.4 | -2.16 | Upgrade
|
| Capital Expenditures | -0 | -0.01 | -0.04 | -0.04 | -0.02 | Upgrade
|
| Cash Acquisitions | - | - | - | -0 | -0.08 | Upgrade
|
| Divestitures | - | - | - | 0.2 | 0.3 | Upgrade
|
| Other Investing Activities | 0.05 | -0 | - | 0 | -0 | Upgrade
|
| Investing Cash Flow | 0.05 | -0.02 | -0.04 | 0.16 | 0.2 | Upgrade
|
| Short-Term Debt Issued | 0.91 | 2.74 | 2.17 | 2.07 | 2 | Upgrade
|
| Long-Term Debt Issued | - | - | 0.01 | 0.15 | - | Upgrade
|
| Total Debt Issued | 0.91 | 2.74 | 2.19 | 2.22 | 2 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0.04 | Upgrade
|
| Long-Term Debt Repaid | - | -0.05 | -0.02 | -0.18 | -0.49 | Upgrade
|
| Total Debt Repaid | - | -0.05 | -0.02 | -0.18 | -0.52 | Upgrade
|
| Net Debt Issued (Repaid) | 0.91 | 2.69 | 2.16 | 2.04 | 1.47 | Upgrade
|
| Issuance of Common Stock | - | - | 0.2 | 1.28 | 0.55 | Upgrade
|
| Other Financing Activities | - | - | -0.04 | -0.1 | - | Upgrade
|
| Financing Cash Flow | 0.91 | 2.69 | 2.33 | 3.22 | 2.02 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.08 | -0.06 | 0.07 | -0.02 | -0.02 | Upgrade
|
| Net Cash Flow | -0.04 | 0.03 | -0.01 | -0.03 | 0.05 | Upgrade
|
| Free Cash Flow | -0.91 | -2.6 | -2.41 | -3.43 | -2.17 | Upgrade
|
| Free Cash Flow Margin | -5178.02% | -1154.07% | -366.31% | -957.84% | -450.17% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.02 | -0.03 | Upgrade
|
| Cash Interest Paid | 0 | - | 0 | 0.01 | 0.04 | Upgrade
|
| Levered Free Cash Flow | 1.03 | -1.75 | -1.02 | -4.36 | -0.81 | Upgrade
|
| Unlevered Free Cash Flow | 1.15 | -1.62 | -0.98 | -4.2 | -0.78 | Upgrade
|
| Change in Working Capital | 1.75 | 0.34 | -0.24 | 0.96 | 0.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.